Linda Bren. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adjuvants, Immunologic/therapeutic useAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedHumansMultiple Sclerosis/drug therapyNatalizumabSecondary Prevention
Substances: See more » Adjuvants, ImmunologicAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedNatalizumab
Year: 2005 PMID: 16121419
Source DB: PubMed Journal: FDA Consum ISSN: 0362-1332